Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
Atrial fibrillation (AF) is a cardiac arrhythmia caused by electrophysiological anomalies in the atrial tissue, tissue degradation, structural abnormalities, and comorbidities. A direct relationship exists between AF and altered mitochondrial activity resulting from membrane potential loss, contract...
Main Authors: | Antônio da Silva Menezes Júnior, Ana Luísa Guedes de França-e-Silva, Joyce Monteiro de Oliveira, Daniela Melo da Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/1/535 |
Similar Items
-
Mitochondrial Dysfunction in Atrial Fibrillation—Mechanisms and Pharmacological Interventions
by: Paweł Muszyński, et al.
Published: (2021-05-01) -
Oxidative Stress, Inflammation, and Mitochondrial Dysfunction: A Link between Obesity and Atrial Fibrillation
by: Alkora Ioana Balan, et al.
Published: (2024-01-01) -
Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation
by: Marit Wiersma, et al.
Published: (2020-05-01) -
The Role of Mitochondrial Dysfunction in Atrial Fibrillation: Translation to Druggable Target and Biomarker Discovery
by: Lisa Pool, et al.
Published: (2021-08-01) -
Pharmacologic Therapy in the Elderly with Atrial Fibrillation
by: Shih-Huang Lee, et al.
Published: (2008-03-01)